Journal: bioRxiv
Article Title: Identification of an osteopontin-derived peptide that binds neuropilin-1 and activates vascular cells
doi: 10.1101/2023.09.05.556237
Figure Lengend Snippet: The effect of FOL-026 treatment on smooth muscle cell proliferation (A) and apoptosis (B) induced by low-oxygen condition were evaluated with the uptake of BrdU (n=10 per group) and active caspase-3/-7 (n=6-8 per group) respectively. H 2 O 2 measurement (C) in smooth muscle cells pre-incubated with FOL-26 peptides following 50μg/ml oxLDL exposure for 2 hours (n=6-7 per group). Representative images of the in vitro wound assay are shown (D) and the ability of wound closure (E) in human coronary smooth muscle cells (HCASMCs) treated with different concentrations of FOL-026 was measured by image J software (n=10 per group). qRT-PCR analysis of collagen type I α 1 chain (COL1A1, F ) and collagen type I α 2 chain (COL1A2, G ) mRNA expression in FOL-026 peptide-stimulated HCASMCs (n=6 for F and G). Western blot analysis of phosphorylated AKT (p-AKT-T308 and p-AKT-S473), t-AKT, phosphorylated ERK1/2 (p-ERK1/2) and t-ERK1/2 in HCASMCs stimulated with FOL-026 (H-J) . Quantification of Akt and ERK1/2 phosphorylation were normalized to respective total protein expressions (n=7 for H, n=9 for I, n=3 for J). Scale bar =150μm in D. Data are presented as means ± SEM and acquired from 3 to 4 independent replicate tests. *P<0.05, **P<0.01, ***P<0.001, and ****P<0.0001 by one-way ANOVA and Dunnett’s post-hoc test.
Article Snippet: Cell proliferation was analyzed with BrdU Cell Proliferation Elisa Kit (Abcam, Cambridge, UK).
Techniques: Incubation, In Vitro, Software, Quantitative RT-PCR, Expressing, Western Blot, Phospho-proteomics